VC  Samsara BioCapital

https://www.samsaracap.com/





     Office Locations:

628 Middlefield Road
Palo Alto, CA 94301
Phone: 650-285-4270

 
Stages:

  • Early


 
Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  
    Description:

    Samsara BioCapital was founded after years of the firm's partners working in the medical field and investment industry. Samsara's culture and philosophy are deeply rooted in a patient-first mentality. Samsara employs a long term, patient, company-build perspective with its portfolio, and collaborates with management to do what is best over the long run for the company, and for patients. Samsara provides capital through a company's full risk cycle and over many years, whether the company is private or public


     
    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Silicon Valley Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     
    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Abe Bassan Principal
    Christian Richard Head of Public Research
    Cory Freedland Partner
    Donnie McCarthy Principal
    Mike Dybbs Partner

     
    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      06/22/2026


      Nura Bio


      CA


      $73,800,000


      Series B


      04/08/2026


      Sidewinder Therapeutics


      CA


      $137,000,000


      Series B


      01/12/2026


      EpiBiologics


      CA


      $107,000,000


      Series B


      12/15/2025


      Link Cell Therapies


      CA


      $60,000,000


      Series A


     
    Portfolio companies include:


      A2 Biotherapeutics
        web link


      Abata Therapeutics
        web link


      Alamar Biosciences
        web link


      Alpha-9 Oncology
        web link


      Alpheus Medical
        web link


      Alumis
        web link


      Atreca


      Bolt Biotherapeutics
        web link


      CARGO Therapeutics
        web link


      Decibel Therapeutics
        web link


      Delfi Diagnostics
        web link


      Dewpoint Therapeutics
        web link


      eGenesis
        web link


      ElevateBio
        web link


      Elevation Oncology
        web link


      EpiBiologics
        web link


      Forma Therapeutics
        web link


      Graphite Bio
        web link


      HilleVax
        web link


      Janux Therapeutics
        web link


      Link Cell Therapies
        web link


      Neurogene
        web link


      Nkarta Therapeutics
        web link


      Normunity
        web link


      Nura Bio
        web link


      Obsidian Therapeutics
        web link


      OrsoBio
        web link


      Palladio
        web link


      Palvella Therapeutics
        web link


      Pipeline Therapeutics
        web link


      RayzeBio


      Recursion Pharmaceuticals
        web link


      Seismic Therapeutic
        web link


      Sidewinder Therapeutics
        web link


      SpringWorks Therapeutics
        web link


      SpyGlass Pharma
        web link


      Synthekine
        web link


      Terns Pharmaceuticals
        web link


      Unum Therapeutics
        web link


      Upstream Bio
        web link


      Vedere Bio II
        web link


      Velicept Therapeutics
        web link


     
    Recent News: